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Introduction
!
Endoscopic ultrasound (EUS) is often employed
for locoregional staging of gastrointestinal malig-
nancy. However, differentiating between benign
andmalignant lymph nodes is still sometimes dif-
ficult based on EUS appearance alone [1,2]. Al-
though EUS-guided fine needle aspiration (FNA)
can obtain diagnostic cytologicmaterial, targeting
of tissue for FNA still depends on imaging, and
there is still an important need for better meth-
ods for distinguishing benign from neoplastic tis-
sue. Our previous studies with mechanical echo
endoscopes have shown that spectral parameters
from backscattered signals can be used to quanti-
tatively distinguish between benign and malig-
nant lymph nodes [3,4].
In spectrum analysis, the radiofrequency (RF)
data of the ultrasound energy that is backscat-
tered from local tissue inhomogeneities is ana-
lyzed [5]. The nature of the backscattered signals
depends on the effective size and acoustic con-
centration of the scattering tissues as well as the
local variations in acoustic impedance (product
of density and sound speed). Different tissue
types may then be distinguished because they
have different microstructures that scatter ultra-
sound differently. Spectral parameters provide a
quantitative assessment that is independent of
the system being used and of the user, given
proper calibration. In the context of gastrointesti-
nal cancer, ex vivo studies of lymph node metas-
tases of colorectal cancer have shown that ultra-
sound backscatter analysis performed better
than B-mode ultrasound [6] even when multiple
B-mode sonographic parameters were considered
[7]. Recent investigations using high frequency
ultrasound (25.6MHz center frequency) to exam-
ine ex vivo lymph node specimens have shown
specificity and sensitivity as high as 95% with
multiple backscatter parameters [8,9].
Over the past decade, radial and curvilinear elec-
tronic array echo endoscopes have widely re-
placed mechanical echo endoscopes. Our aim in
this study was to test the ability of spectral analy-
sis of EUS backscattered signals to distinguish be-
tween benign and malignant lymph nodes using
data obtained from electronic array echo endo-
scopes.
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Our purpose was to demonstrate the use of radio-
frequency spectral analysis to distinguish be-
tween benign and malignant lymph nodes with
data obtained using electronic array echo endo-
scopes, as we have done previously using me-
chanical echo endoscopes. In a prospective study,
images were obtained from eight patients with
benign-appearing lymph nodes and 11 with ma-
lignant lymph nodes, as verified by fine-needle
aspiration. Midband fit, slope, intercept, correla-
tion coefficient, and root-mean-square (RMS) de-
viation from a linear regression of the calibrated
power spectra were determined and compared
between the groups. Significant differences were
observable for mean midband fit, intercept, and
RMS deviation (t test P<0.05). For benign (n=16)
vs. malignant (n=12) lymph nodes, midband fit
and RMS deviation provided classification with
89% accuracy and area under receiver operating
characteristic (ROC) curve of 0.95 based on linear
discriminant analysis. We concluded that the
mean spectral parameters of the backscattered
signals from electronic array echo endoscopy can
provide a noninvasive method to quantitatively
discriminate between benign and malignant
lymph nodes.
 
Patients and methods
!
Diagnostic criteria
Patients in the benign node group met all of the following crite-
ria: (i) referred for EUS for reasons other than cancer staging; (ii)
no prior or current diagnosis of malignancy; (iii) no identification
of mass lesions at EUS; (iv) each lymph node showing at least one
of the following EUS features suggestive of benign nodes: (a)
draping configuration (b) hyperechoicity (c) node diameter
< 1cm; (v) no diagnosis of cancer in the year following EUS exam-
ination as determined by follow-up telephone questionnaire and/
or review of medical records.
Patients in the malignant node group met both the following
criteria: (i) lymph node identified at EUS; (ii) FNA cytology posi-
tive for carcinoma.
Patients
A total of 19 patients were included in the study. FNA-provenma-
lignant lymphadenopathy was shown in 11 patients, associated
with malignancy of the pancreas (n=3), lymphoma (n=2), rec-
tum (n=1), lung (n=2), and esophagus (n=3). Benign-appearing
lymph nodes were imaged in eight patients, without a diagnosis
of malignancy. Indications for these procedures were incidental
mediastinal adenopathy (n=3), benign pancreatic disease (n=4),
and gastrointestinal stromal tumor (GIST) (n=1). In some cases,
multiple lymph nodes were imaged in a patient.
RF data acquisition and analysis
We used radial (GF-UE160-AL5) and curvilinear (GF-UC140P-
AL5) electronic-array ultrasonic gastrovideoscopes operated in
the 6MHz mode with a commercially available clinical ultra-
sound system (Exera EU-ME1; Olympus America, Center Valley,
Pennsylvania, USA). The echo endoscopes contain ultrasound
transducer arrays which are electronically excited in sets to gen-
erate 360° (radial) or 180° (curvilinear) B-scan cross-sectional
images, composed of hundreds of A-scan lines. Each image and
its corresponding RF data were simultaneously digitized by the
Exera EU-ME1 system and automatically saved.
We then imported the RF data into our custom-designed analysis
software (written using MATLAB 2010b; Mathworks, Natick,
Massachusetts, USA) for offline image reconstruction and data
processing. We independently verified that the gain, contrast,
line density, and frame correlation settings, which affect the ap-
pearance of the system image, did not change the underlying RF
data acquired by the system.
Prior to RF data analysis, clinical endoscopists identified and
manually segmented regions of interest (ROIs) on the system im-
age according to the evaluation criteria described below. Data
analysts then independently translated the ROIs onto the recon-
structed image to select corresponding segments of RF data. The
sector-shaped ROIs were maximized in size within the desig-
nated areas. The fast Fourier transform (FFT) was used to find
the power spectra for each segment of A-scan RF data within the
ROI after gating the segment by a series of sliding Hamming win-
dows of 0.8μs (~0.62mm), each offset by 0.1μs (~0.077mm).
●" Fig.1a shows a typical example of an ROI chosen for a lymph
node using the curvilinear echoendoscope, while ●" Fig.1b
shows that the FNA used to determine the malignancy of the
node was obtained in the same tissue area under EUS guidance.
Spectrum calibration
Previous studies have typically removed the artifacts associated
with the composite transfer function of the electronic transmit-
ter/receiver and transducer of the EUS system by dividing the
power spectrum from the tissue by the spectrum of an ideal re-
flector. However, we did not have control over the electronic
gain settings for the RF data acquisition (not the image gain set-
ting), and, as such, we could not use a strong ultrasound reflector
(e.g., glass) without saturating the received signal from an ideal
reflector. Instead, calibration was performed using reflections
from the flat wall of an acrylic plastic chamber filled with an at-
tenuating gelatin-based phantom [4]. The phantom material was
independently measured using the substitution method to have
an attenuation of 1.5dB/MHz/cm, which was sufficient to pre-
vent signal saturation while minimally affecting overall spectral
shape.
To obtain the RF calibration data, an 18-mm hole in the phantom
was filled with water. We then inserted the transducer, and infla-
ted the endoscope’s balloon with water until the balloon was in
full contact with the phantom. We manually adjusted the orien-
tation of the endoscope tip to make the central axis of the endo-
scope parallel to the wall. We then acquired the RF data, and
computed by spectrum by FFT. The calibration spectrum was
then compensated for round-trip attenuation. To obtain the cali-
brated spectra, we then divided the tissue spectra by the calibra-
tion spectrum.
Because the calibrated spectra are typically quasilinear over the
ultrasound frequency band used [3], they can be effectively char-
acterized by linear regression using their slope, intercept, and
their midband fit, which is the value of the linear function eval-
Fig.1 Lymph node characterization in vivo using
endoscopic ultrasound (EUS) and radiofrequency
(RF) spectrum analysis: selection of region of inter-
est (ROI), and fine needle aspiration (FNA).
a System image of a lymph node showing superim-
posed typical ROI selection. The RF EUS data under-
lying the image was acquired prior to FNA.
b EUS-guided FNA of the same tissue area. Subse-
quent cytological analysis showed that the node
was malignant.
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uated at the midpoint of the −15-dB frequency bandwidth. We
corrected both the midband fit and slope values for the attenua-
tion of the intervening tissue between the transducer and the
ROI, using an assumed attenuation of 0.5dB/MHz/cm; the inter-
cept is not affected by this attenuation correction [5]. We also re-
corded the square of the correlation coefficient, R2, and the root-
mean-square (RMS) deviation of the regression line as normal-
ized and unnormalized measures of the deviation of the cali-
brated spectrum from linearity.
Statistical analysis.
To obtain a single value for each ROI, we averaged the spectral
parameters generated from each window over each ROI. We
then analyzed the resulting values using Student’s t test for inde-
pendent samples. The t tests assumed equal variance, and all
parameters satisfied the Shapiro–Wilk normality test. Once we
had identified parameters that had statistically significant differ-
ences between group means, we performed linear discriminant
analysis (LDA) to classify the data using equal prior probabilities
for each group and the within-groups covariance matrix. For LDA
where the same data was used for training and testing, we used
the leave-one-out approach for cross-validation.
We performed all statistical calculations using SPSS (Version 16,
SPSS, Chicago, Illinois, USA).We fitted a binormal receiver operat-
ing characteristic (ROC) curve to the resulting discriminant
scores by using ROCKIT (Version 1.1B2, University of Chicago,
Chicago, IL, USA), and then assessed classification performance
by computing the area under the ROC curve (AUC) from ROCKIT.
Results
!
●" Tab.1 lists the means and standard deviations of the sets of
mean spectral parameters obtained from averaging over the
ROIs for each benign and malignant lymph node. The t tests
showed that midband fit, intercept, and RMS deviation were sig-
nificantly different between the benign and malignant nodes
with the malignant nodes having lower midband fit and inter-
cept, but greater RMS deviation.
●" Tab.2 shows the results of the LDA classification using mid-
band fit and RMS deviation and leave-one-out cross-validation.
The canonical discriminant function coefficients were −0.108 for
the midband fit, and 1.704 for the RMS deviation, with a constant
value of −14.877. (The use of intercept and RMS deviation or in-
Table 1 Lymph node characterization in vivo using endoscopic ultrasound
(EUS) and radiofrequency spectrum analysis. Descriptive statistics and hy-
pothesis testing results for lymph node data. Columns 2 and 3 show the
means and standard deviations of spectral parameters averaged over the re-
gions of interest for benign and malignant lymph nodes. Column 4 lists the P
values resulting from application of Student’s t test, assuming equal variance
between groups.
Benign
lymph nodes
(n=16)
Malignant
lymph nodes
(n=12)
P value
Mean spectral parameter
Midband fit, dB −61.3 ± 4.8 −69.0 ± 4.1 < 0.001
Slope, dB/MHz 0.087 ± 0.57 0.28 ± 0.79 0.16
Intercept, dB −60.7 ± 3.7 −70.8 ± 9.2 < 0.001
Correlation coefficient R2 0.29 ± 0.08 0.27 ± 0.08 0.54
RMS deviation, dB 4.32 ± 0.30 5.07 ± 0.49 < 0.001
RMS, root-mean-square
Table 2 Lymph node characterization in vivo using endoscopic ultrasound
(EUS) and radiofrequency spectrum analysis. Results from linear discriminant
analysis of lymph node data. Classification was performed using midband fit
and root-mean-square (RMS) deviation as independent variables, and the re-
ported values used “leave-one-out” cross-validation. The overall accuracy of
classification was 89%. (See●" Fig. 2 for the corresponding scatterplot and
receiver operating characteristic [ROC] curve.)
Predicted state, n (%) Total
Malignant Benign
Tissue state
Malignant 10 (83.3) 2 (16.7) 12 (100)
Benign 1 (6.3) 15 (93.8) 16 (100)
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Fig.2 Linear discriminant analysis (LDA) and receiver operating charac-
teristic (ROC) curve for the lymph node data. a Scatterplot of data with co-
ordinates given by midband fit and root mean square (RMS) deviation. The
dividing line between benign and malignant classification is based on LDA.
b Corresponding binormal maximum likelihood estimate of the ROC curve.
The area under the curve is 0.95 (See●" Tab. 2 for the corresponding clas-
sification matrix.).
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tercept and midband fit gave comparable or worse results.) With
the malignant outcome considered a “positive” test result, the
classification had sensitivity of 83%, specificity of 94%, positive
predictive value of 91%, negative predictive value of 88%, and
overall accuracy of 89%.
●" Fig.2a shows the corresponding scatterplot of the data using
midband fit and RMS deviation. The discriminant line shows the
approximate dividing line between benign and malignant cases
according to the LDA.●" Fig.2b shows the corresponding binor-
mal estimate of the ROC curve with AUC of 0.95.
Discussion
!
In our previous studies, midband fit and intercept were found to
best distinguish benign and malignant lymph nodes, although
only with a maximum sensitivity of 67%, specificity of 82%, over-
all accuracy of 73%, and ROC AUC of 0.90 with all data from both
studies [4], and therefore below the level of the current results. In
those studies two different echo endoscopes had to be used to
obtain the RF data and FNA biopsies; however in the current
study the curvilinear echoendoscope could obtain both at once
(see●" Fig.1). It is possible that this factor could account for the
improved classification. In the current study we also computed
the RMS deviation and found that it provided another relatively
uncorrelated parameter for discrimination between the benign
and malignant nodes.
The lower midband fit and intercept observed here are consistent
with our previous studies with the single-element echo endo-
scopes. The ability of intercept to distinguish between benign
and malignant lymph nodes is consistent with previously report-
ed results for ex vivo lymph nodes, using single-element transdu-
cers with metastases from colorectal [6] and breast [10] cancers
(−15dB bandwidth of 4.5–11MHz) as well as cancerous lymph
nodes from breast, colon, and gastric cancers at higher frequen-
cies (−6dB bandwidth of 16.4–33.6MHz) [8, 9]. These studies re-
ported higher (less negative) intercepts for metastatic nodes and
also observed significant differences in slope between benign
and malignant nodes. However, it may be difficult to exactly
compare these results with the current study given the different
transducer types and more highly controlled conditions of the ex
vivo studies.
Additional work will be useful to address the limitations of this
study. Because histological results were only available for cases
with suspected malignancy (malignant lymph nodes), the benign
cases had to be inferred from other more indirect clinical and
“classic” EUS diagnosis criteria. As such, the study only included
fairly well-defined cases, and additional work is needed to assess
the utility of the approach in more ambiguous situations. Also,
the modest sample size precluded the use of additional criteria
(e.g., texture or morphological parameters) with more sophisti-
cated classification methods (e.g., support vector machines) that
could result in an improved ability to discriminate between tis-
sue states.
Conclusion
!
This study shows that spectral analysis of the EUS RF backscatter
signals from radial and curvilinear electronic-array echo endo-
scopes can discriminate between benign and malignant lymph
nodes in vivo. With further development, this methodmay prove
useful for providing real-time ‘‘digitally stained’’ images with col-
oration corresponding to the probability of various normal or dis-
ease states, thereby providing endoscopists withmore timely and
improved accuracy of diagnosis with EUS.
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